Cargando…
Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance
BACKGROUND: Evidence suggests that the PPARγ-agonist insulin sensitizer pioglitazone, may provide potential beneficial cardiovascular (CV) effects beyond its anti-hyperglycaemic function. A reduced endothelial progenitor cell (EPC) number is associated with impaired glucose tolerance (IGT) or diabet...
Autores principales: | Spigoni, Valentina, Picconi, Angela, Cito, Monia, Ridolfi, Valentina, Bonomini, Sabrina, Casali, Chiara, Zavaroni, Ivana, Gnudi, Luigi, Metra, Marco, Dei Cas, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489677/ https://www.ncbi.nlm.nih.gov/pubmed/23139771 http://dx.doi.org/10.1371/journal.pone.0048283 |
Ejemplares similares
-
Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes
por: Dei Cas, Alessandra, et al.
Publicado: (2017) -
Effects of TiO(2) and Co(3)O(4) Nanoparticles on Circulating Angiogenic Cells
por: Spigoni, Valentina, et al.
Publicado: (2015) -
Effects on Nitric Oxide Production of Urolithins, Gut-Derived Ellagitannin Metabolites, in Human Aortic Endothelial Cells
por: Spigoni, Valentina, et al.
Publicado: (2016) -
Transcriptomic Analysis of Human Polarized Macrophages: More than One Role of Alternative Activation?
por: Derlindati, Eleonora, et al.
Publicado: (2015) -
Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects
por: Matone, Alice, et al.
Publicado: (2019)